Minerva Neurosciences' average one-year price target was raised to $9.69 per share from $7.40, a 31.03% increase versus the prior estimate dated April 12, 2026. The update reflects improved analyst expectations rather than operating results or company guidance. The article is likely modestly supportive for sentiment, but the direct market impact should be limited.
Minerva Neurosciences' average one-year price target was raised to $9.69 per share from $7.40, a 31.03% increase versus the prior estimate dated April 12, 2026. The update reflects improved analyst expectations rather than operating results or company guidance. The article is likely modestly supportive for sentiment, but the direct market impact should be limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
